Get the Stockscreener App
14.57
2.51%
-0.375
Vtv Therapeutics Inc stock is traded at $14.57, with a volume of 2,579.
It is down -2.51% in the last 24 hours and down -0.65% over the past month.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.
See More
Previous Close:
$14.95
Open:
$14.55
24h Volume:
2,579
Relative Volume:
0.39
Market Cap:
$38.15M
Revenue:
$5.02M
Net Income/Loss:
$-18.31M
P/E Ratio:
-3.2174
EPS:
-4.53
Net Cash Flow:
$-23.40M
1W Performance:
-6.21%
1M Performance:
-0.65%
6M Performance:
-9.98%
1Y Performance:
-0.44%
1-Day Range:
$14.54
$14.57
1-Week Range:
$14.54
$15.30
52-Week Range:
$12.58
$26.99
Vtv Therapeutics Inc Stock (VTVT) Company Profile
Name
Vtv Therapeutics Inc
Sector
Industry
Phone
336-841-0300
Address
3980 PREMIER DR, HIGH POINT, NC
Compare VTVT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
14.57 | 39.13M | 5.02M | -18.31M | -23.40M | -4.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-30-19 | Initiated | H.C. Wainwright | Buy |
| Apr-10-18 | Downgrade | Stifel | Buy → Hold |
| Mar-08-18 | Initiated | ROTH Capital | Buy |
| Feb-08-18 | Initiated | Northland Capital | Outperform |
| Sep-26-16 | Initiated | H.C. Wainwright | Buy |
| Sep-04-15 | Initiated | Canaccord Genuity | Buy |
| Aug-24-15 | Initiated | Piper Jaffray | Overweight |
| Aug-24-15 | Initiated | Stifel | Buy |
View All
Vtv Therapeutics Inc Stock (VTVT) Latest News
Advanced analytics toolkit walkthrough for vTv Therapeutics Inc.Free Long Hold Safe Return Strategy - Newser
Custom strategy builders for tracking vTv Therapeutics Inc.Conservative Asset Allocation Risk Analysis - Newser
Relative strength of vTv Therapeutics Inc. in sector analysisVolume Based Swing Signal Prediction Map - Newser
What are the technical indicators suggesting about vTv Therapeutics Inc.Invest smarter with data-backed trading alerts - jammulinksnews.com
What are analysts’ price targets for vTv Therapeutics Inc. in the next 12 monthsAchieve breakthrough financial growth - jammulinksnews.com
Is vTv Therapeutics Inc. a growth stock or a value stockDiscover undervalued opportunities early - jammulinksnews.com
Why vTv Therapeutics Inc. stock attracts strong analyst attentionShort-Term Bounce Forecast for Oversold Stocks - Newser
Using data models to predict vTv Therapeutics Inc. stock movementFree Market Entry and Exit Point Tips - Newser
Should I buy vTv Therapeutics Inc. stock before earningsFree Stock Market Watch With Alerts - newser.com
Is it the right time to buy vTv Therapeutics Inc. stockAccelerated wealth building - jammulinksnews.com
Should I hold or sell vTv Therapeutics Inc. stock in 2025Free Stock Selection - jammulinksnews.com
What are vTv Therapeutics Inc. company’s key revenue driversStay informed with expert market forecasts - jammulinksnews.com
Is vTv Therapeutics Inc. a good long term investmentFree Stock Market Beginners Guide - jammulinksnews.com
vTv Therapeutics Inc. stock daily chart insightsFree Technical Entry Strategy for Beginners - Newser
vTv Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFundamental + Technical Combined Watchlist - Newser
How Resilient Is vTv Therapeutics Inc. Stock During Economic DownturnsFree Intraday Trend Analysis for Fast Gains - Newser
How vTv Therapeutics Inc. stock performs during market volatilityFree Fundamental Growth Stock Analysis - Newser
What makes vTv Therapeutics Inc. stock price move sharplyEntry Opportunity Screener with Confirmation - Newser
Quant Tools Rank vTv Therapeutics Inc. as High Risk High RewardOversold Bounce Stock Play Ideas Gain Attention - metal.it
vTv Therapeutics Inc. Breakout Confirmed by Volume MetricsAI Screening for Swing Trade Picks Finds Momentum - metal.it
How many analysts rate vTv Therapeutics Inc. as a “Buy”Record-breaking capital gains - jammulinksnews.com
vTv Therapeutics Inc. Stock Support and Resistance Levels You Should KnowFree ROI Driven Equity Selection With Safety - Newser
Is vTv Therapeutics Inc. stock overvalued or undervaluedHigh-performance investment picks - jammulinksnews.com
What catalysts could drive vTv Therapeutics Inc. stock higher in 2025Unlock your trading potential today - jammulinksnews.com
What is the dividend policy of vTv Therapeutics Inc. stockSky-high profits - jammulinksnews.com
Buy Signal for vTv Therapeutics Inc. Stock Key Technical Indicators to Watch3x Return Stock Radar - Newser
What risks could impact vTv Therapeutics Inc. stock performanceSuperior profit margins - jammulinksnews.com
What analysts say about vTv Therapeutics Inc. stockBreakout profit opportunities - PrintWeekIndia
vTv Therapeutics Inc. Stock Analysis and ForecastSuperior return velocity - PrintWeekIndia
Vtv Therapeutics Inc Stock (VTVT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):